News
Biotech company, NRG Therapeutics, has today announced an Innovate UK award to continue its drug development project, supported by the Parkinson's Virtual Biotech, into life-changing new treatments.
Research led by Cambridge University and part funded by Parkinson's UK shows that a form of brain scan could help identify those at risk of specific Parkinson's symptoms.
A trial of a new miniaturised deep brain stimulation (DBS) device, being carried out at Southmead Hospital in Bristol, aims to make improvements to existing surgery.
A pioneering partnership between global biopharmaceutical company UCB, Parkinson's UK and the Parkinson's Foundation in the US is laying the foundations for people with Parkinson's to feed into the drug development pipeline.
A new partnership between Alex Echo, Hydrow and Parkinson's UK will raise awareness of Parkinson's and the benefits of physical activity.
As a new clinical trial begins, we explore the potential and next steps for a Parkinson's watch that monitors symptoms.
James, who was most recently with the British Heart Foundation, replaces Annie Macleod who retired at the end of last year.
Physical activity is good for you. It's especially good for you if you have Parkinson's. That's why we've partnered with Everyone Active to offer free membership to its leisure centres for people with Parkinson's and their carers.
An app for people with Parkinson's to remotely monitor and manage their non-motor symptoms is now entering the testing phase.
New research from Lancaster University reveals the imapct of the pandemic on people with Parkinson's, carers and their families